Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of rTMS on Individualized dlPFC-NAcc Functional Connectivity in Adolescents With Depression and Anhedonia: a Randomized Clinical Trial

NCT05544071 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05544071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05544071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of rTMS on Individualized dlPFC-NAcc Functional Connectivity in Adolescents With Depression and Anhedonia: a Randomized Clinical Trial
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2023
Completion date
July 31, 2024
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, repetitive transcranial magnetic stimulation